Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Screener

PROF

Profound Medical Corp

May 17 • 04:00PM ET

8.29

Dollar change -0.19
Percentage change -2.30	%

Healthcare • Medical Devices • Canada • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: DFIS DFIC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.28	Insider Own	8.98%	Shs Outstand	24.43M	Perf Week	7.24%
Market Cap	202.52M	Forward P/E	-	EPS next Y	-0.90	Insider Trans	0.00%	Shs Float	22.23M	Perf Month	5.74%
Income	-28.03M	PEG	-	EPS next Q	-0.28	Inst Own	39.37%	Short Float	1.40%	Perf Quarter	-2.47%
Sales	7.25M	P/S	27.93	EPS this Y	16.17%	Inst Trans	-	Short Ratio	9.16	Perf Half Y	-12.18%
Book/sh	1.88	P/B	4.42	EPS next Y	20.32%	ROA	-47.25%	Short Interest	0.31M	Perf Year	-38.86%
Cash/sh	1.69	P/C	4.92	EPS next 5Y	-	ROE	-59.26%	52W Range	7.11 - 15.49	Perf YTD	-2.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	3.31%	ROI	-60.46%	52W High	-46.48%	Beta	0.79
Dividend TTM	-	Quick Ratio	4.73	Sales past 5Y	36.38%	Gross Margin	61.22%	52W Low	16.60%	ATR (14)	0.48
Dividend Ex-Date	-	Current Ratio	5.41	EPS Y/Y TTM	1.70%	Oper. Margin	-403.64%	RSI (14)	55.47	Volatility	6.51% 6.18%
Employees	131	Debt/Eq	0.16	Sales Y/Y TTM	1.00%	Profit Margin	-386.63%	Recom	2.00	Target Price	12.92
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	20.79%	Payout	-	Rel Volume	0.27	Prev Close	8.48
Sales Surprise	-21.67%	EPS Surprise	12.61%	Sales Q/Q	2.69%	Earnings	May 09 AMC	Avg Volume	33.88K	Price	8.29
SMA20	6.27%	SMA50	2.99%	SMA200	-6.06%	Trades		Volume	9,112	Change	-2.30%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-28-23	Initiated	Stifel	Hold	$11
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform	$20 → $200
Mar-21-23	Downgrade	Jefferies	Buy → Hold	$5.50 → $10
Sep-15-20	Initiated	Jefferies	Buy

May-16-24 09:18AM	Profound Medical (PROF) Adds AI to Prostate Cancer Treatment (Zacks)
May-15-24 05:00PM	Profound Medical Annual General Meeting of Shareholders Voting Results (GlobeNewswire)
May-14-24 07:30AM	Profound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan (GlobeNewswire) +7.32%
May-13-24 10:46AM	Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 08:55PM	PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.60%
04:05PM	Loading…
04:05PM	Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance (GlobeNewswire)
May-06-24 04:15PM	Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum (GlobeNewswire)
Apr-22-24 04:15PM	Profound Medical to Release First Quarter 2024 Financial Results on May 9 Conference Call to Follow (GlobeNewswire)
Apr-09-24 07:45AM	Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Mar-08-24 03:31PM	Profound Medical Corp. (NASDAQ:PROF) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.86%
Mar-07-24 09:54PM	PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 04:30PM	Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-01-24 11:58AM	Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer (Zacks)
Feb-27-24 07:45AM	Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure (GlobeNewswire)
04:30PM	Loading…
Feb-15-24 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 Conference Call to Follow (GlobeNewswire)
Jan-29-24 09:08AM	Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
Jan-26-24 09:55AM	How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06% (Zacks) +9.42%
Jan-16-24 04:30PM	Profound Medical Announces Non-Brokered Private Placement (GlobeNewswire)
Jan-03-24 04:15PM	Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues (GlobeNewswire)
Dec-27-23 10:40PM	Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares (GlobeNewswire) -8.49%
04:15PM	Profound Medical Announces Proposed Public Offering of Common Shares (GlobeNewswire)
Nov-08-23 07:45AM	Profound Medical to Participate in the Stifel 2023 Healthcare Conference (GlobeNewswire)
Nov-05-23 12:07PM	Profound Medical Corp. (NASDAQ:PROF) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 08:00AM	Profound Medical Announces CMS Extension of Temporary 'Code' for TULSA to ASC Setting (GlobeNewswire)
Nov-02-23 04:05PM	Profound Medical Announces Third Quarter 2023 Financial Results (GlobeNewswire) +8.02%
Oct-19-23 04:30PM	Profound Medical to Release Third Quarter 2023 Financial Results on November 2 Conference Call to Follow (GlobeNewswire)
Oct-10-23 04:30PM	Profound Medical 2023 Virtual Analyst & Investor Day Agenda (GlobeNewswire)
Sep-25-23 04:05PM	Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost (GlobeNewswire)
Sep-21-23 08:00AM	Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13 (GlobeNewswire)
04:45PM	Loading…
Sep-19-23 04:45PM	Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 07:23PM	Profound Medical Announces At-the-Market Offering of up to US$30,000,000 (GlobeNewswire)
Aug-09-23 04:05PM	Profound Medical Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-02-23 04:30PM	Profound Medical to Release Second Quarter 2023 Financial Results on August 9 Conference Call to Follow (GlobeNewswire)
Jun-02-23 01:40PM	Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases (GlobeNewswire) +10.30%
May-30-23 08:00AM	Profound Medical Announces Upcoming Investor Events (GlobeNewswire) +5.29%
May-18-23 08:00AM	Profound Medical to Participate in A.G.P.s Virtual Healthcare Conference (GlobeNewswire)
May-17-23 04:15PM	Profound Medical Annual and Special Meeting of Shareholders Voting Results (GlobeNewswire)
May-10-23 04:05PM	Profound Medical Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 04:30PM	TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting (GlobeNewswire) +5.60%
Apr-19-23 04:30PM	Profound Medical to Release First Quarter 2023 Financial Results on May 10 Conference Call to Follow (GlobeNewswire) +6.07%
04:15PM	Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Mar-07-23 04:05PM	Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-01-23 04:30PM	Profound Medical to Present at the 43rd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-14-23 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 Conference Call to Follow (GlobeNewswire)
Nov-08-22 04:30PM	Profound Medical to Present at the 2022 Jefferies London Healthcare Conference (GlobeNewswire)
Nov-03-22 04:05PM	Profound Medical Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-13-22 04:30PM	Profound Medical to Release Third Quarter 2022 Financial Results on November 3 Conference Call to Follow (GlobeNewswire)
Sep-26-22 08:00AM	Four Year Follow-Up Data from Profound Medicals TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer (GlobeNewswire)
Sep-15-22 08:00AM	Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth (GlobeNewswire)
Sep-06-22 04:30PM	Profound Medical to Participate in September Investor Conferences (GlobeNewswire) -14.11%
Sep-02-22 12:05PM	Profound Medical Provides TULSA-PRO® Reimbursement Update (GlobeNewswire) -5.30%
Aug-04-22 04:05PM	Profound Medical Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-14-22 04:30PM	Profound Medical to Release Second Quarter 2022 Financial Results on August 4 Conference Call to Follow (GlobeNewswire)
Jun-16-22 04:30PM	Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference (GlobeNewswire)
Jun-07-22 07:56AM	What You Need To Know About Profound Medical Corp.'s (TSE:PRN) Investor Composition (Simply Wall St.)
Jun-02-22 04:30PM	Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference (GlobeNewswire) +6.36%
May-18-22 05:43PM	Profound Medical Annual and Special Meeting of Shareholders Voting Results (GlobeNewswire)
04:30PM	Profound Medical Clarifies Recent Insider Buying (GlobeNewswire)
May-17-22 05:25PM	TULSA-PRO® Was Front and Center at AUA2022 (GlobeNewswire)
May-15-22 08:08AM	Trade Alert: The Independent Lead Director Of Profound Medical Corp. (TSE:PRN), Brian Ellacott, Has Just Spent US$459k Buying 278% More Shares (Simply Wall St.)
May-09-22 04:05PM	Profound Medical Announces First Quarter 2022 Financial Results (GlobeNewswire) -7.59%
Apr-25-22 04:30PM	Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-18-22 04:30PM	Profound Medical to Release First Quarter 2022 Financial Results on May 9 Conference Call to Follow (GlobeNewswire) -8.46%
Mar-04-22 04:48AM	Companies Like Profound Medical (TSE:PRN) Are In A Position To Invest In Growth (Simply Wall St.)
Mar-03-22 04:03PM	Profound Medical Announces Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) -6.85%
Mar-02-22 08:00AM	Profound Medical to Participate in March Investor Conferences (GlobeNewswire)
Mar-01-22 07:00AM	Profound Medicals TULSA-PRO® Now Compatible with GE Healthcares 3T MRI Scanners (GlobeNewswire)
Feb-24-22 03:00PM	Profound Medical (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-10-22 04:30PM	Profound Medical to Release Fourth Quarter and Full Year 2021 Financial Results on March 3 Conference Call to Follow (GlobeNewswire) -5.23%
Feb-08-22 04:30PM	Profound Medical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference (GlobeNewswire)
Jan-18-22 07:48AM	Bullish Profound Medical Corp. (TSE:PRN) insiders filled their treasuries with US$782k worth of stock over last year (Simply Wall St.)
07:33AM	Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy (GlobeNewswire)
Jan-05-22 08:00AM	Kenneth Knudson Joins Profound Medical as Chief Commercial Officer (GlobeNewswire) +5.89%
Dec-03-21 12:23PM	Do Institutions Own Profound Medical Corp. (TSE:PRN) Shares? (Simply Wall St.)
Nov-04-21 04:03PM	Profound Medical Announces Third Quarter 2021 Financial Results (GlobeNewswire)
Nov-01-21 04:30PM	Profound Medical to Participate in November Virtual Investor Conferences (GlobeNewswire)
Oct-28-21 03:05PM	Will Profound Medical (PROF) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-18-21 04:45PM	Profound Medical to Release Third Quarter 2021 Financial Results on November 4 Conference Call to Follow (GlobeNewswire)
Oct-04-21 09:02AM	Profound Medical (TSE:PRN) shareholders have earned a 41% CAGR over the last three years (Simply Wall St.)
Sep-08-21 04:30PM	Profound Medical to Participate in September Virtual Investor Conferences (GlobeNewswire)
Aug-19-21 10:41AM	We're Not Worried About Profound Medical's (TSE:PRN) Cash Burn (Simply Wall St.)
Aug-04-21 04:05PM	Profound Medical Announces Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-28-21 03:03PM	PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-22-21 04:30PM	Profound Medical to Participate in A.G.P.s Virtual MedTech Summer Conference (GlobeNewswire)
Jul-15-21 04:30PM	Profound Medical to Release Second Quarter 2021 Financial Results on August 4 Conference Call to Follow (GlobeNewswire) -6.20%
Jul-05-21 08:36AM	When Will Profound Medical Corp. (TSE:PRN) Become Profitable? (Simply Wall St.)
May-25-21 04:30PM	Profound Medical to Participate in June Investor Conferences (GlobeNewswire)
May-20-21 03:20AM	What Type Of Shareholders Make Up Profound Medical Corp.'s (TSE:PRN) Share Registry? (Simply Wall St.)
May-12-21 04:13PM	Profound Medical Announces First Quarter 2021 Financial Results (GlobeNewswire) -6.27%
02:30PM	Profound Medical Corp. to Host Earnings Call (ACCESSWIRE)
May-06-21 07:00AM	Profound Medical and Akumin Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO® (GlobeNewswire) +10.61%
07:00AM	Akumin and Profound Medical Enter into U.S. Multi-Center Commercial Agreement for TULSA-PRO® (PR Newswire)
May-05-21 03:00PM	Analysts Estimate PROFOUND MEDICL (PROF) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-21-21 04:30PM	Profound Medical to Release First Quarter 2021 Financial Results on May 12 Conference Call to Follow (GlobeNewswire)
Apr-14-21 04:30PM	Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference (GlobeNewswire)
Apr-05-21 06:18AM	Is Profound Medical's (TSE:PRN) Share Price Gain Of 176% Well Earned? (Simply Wall St.)
Mar-03-21 07:00AM	Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors (GlobeNewswire)
Mar-02-21 04:02PM	Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results (GlobeNewswire)
02:30PM	Profound Medical Corp. to Host Earnings Call (ACCESSWIRE)

Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.

PROF

Profound Medical Corp

Upgrade your FINVIZ experience